These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2965510)

  • 1. Seroresponse to hepatitis B vaccine in patients and staff of renal dialysis centers, Wisconsin.
    Steketee RW; Ziarnik ME; Davis JP
    Am J Epidemiol; 1988 Apr; 127(4):772-82. PubMed ID: 2965510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination against hepatitis B in children and adolescent patients on dialysis.
    Drachman R; Isacsohn M; Rudensky B; Drukker A
    Nephrol Dial Transplant; 1989; 4(5):372-4. PubMed ID: 2528085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B vaccines in patients with chronic renal failure before dialysis.
    Seaworth B; Drucker J; Starling J; Drucker R; Stevens C; Hamilton J
    J Infect Dis; 1988 Feb; 157(2):332-7. PubMed ID: 2961818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of vaccination with the hepatitis B vaccine in patients and personnel at the Hemodialysis Center in Karlovac].
    Palmović D; Vitas B; Doko A; Belavić Z; Racki L
    Lijec Vjesn; 1989 Nov; 111(11):400-4. PubMed ID: 2534601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poor response to a recombinant hepatitis B vaccine in dialysis patients.
    Fleming SJ; Moran DM; Cooksley WG; Faoagali JL
    J Infect; 1991 May; 22(3):251-7. PubMed ID: 1830073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the response to the recombinant vaccine against hepatitis B virus in dialyzed and nondialyzed children with CRF using different doses and routes of administration.
    Vazquez G; Mendoza-Guevara L; Alvarez T; Aguilar A; Morales A; Rodriguez F; Solorzano F; Garcia-Lopez E; Muñoz O
    Adv Perit Dial; 1997; 13():291-6. PubMed ID: 9360702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting responsiveness to hepatitis B immunization in dialysis patients.
    Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş
    Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B vaccine use in chronic hemodialysis centers in the United States.
    Alter MJ; Favero MS; Maynard JE
    JAMA; 1985 Dec; 254(22):3200-2. PubMed ID: 2933534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immune response to hepatitis B vaccine and duration of protection in a dialysis unit].
    Magnani G; Calzetti C; Campari M; Lehndorff H; Pizzaferri P; Rossi E
    Acta Biomed Ateneo Parmense; 1987; 58(1-2):41-7. PubMed ID: 2960120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B vaccination in chronic renal failure patients undergoing haemodialysis: the immunogenicity of an increased dose of a recombinant DNA hepatitis B vaccine.
    Guan R; Tay HH; Choong HL; Yap I; Woo KT
    Ann Acad Med Singap; 1990 Nov; 19(6):793-7. PubMed ID: 2151841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National surveillance of dialysis-associated diseases in the United States, 1989.
    Alter MJ; Favero MS; Moyer LA; Bland LA
    ASAIO Trans; 1991; 37(2):97-109. PubMed ID: 1830208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of immunisation with a recombinant yeast-derived hepatitis B vaccine.
    Jilg W; Deinhardt F
    J Infect; 1986 Jul; 13 Suppl A():47-51. PubMed ID: 2943815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: the adjuvant role of thymopentin on immunological response to hepatitis B virus vaccine in end-stage renal disease.
    Fabrizi F; Dixit V; Martin P
    Aliment Pharmacol Ther; 2006 Jun; 23(11):1559-66. PubMed ID: 16696803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
    Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Vaccination against hepatitis B in patients with chronic renal failure--twenty years follow-up].
    Roznovský L; Tvrdík J; Kabieszová L; Petrousová L; Orságová I; Hozáková L; Lochman I; Kloudová A; Valkovský I; Letocha P; Schwarzová S; Hladík M; Zjevíková A
    Vnitr Lek; 2011 Oct; 57(10):808-14. PubMed ID: 22097688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody response to hepatitis B vaccine in end-stage renal disease patients.
    Chow KM; Law MC; Leung CB; Szeto CC; Li PK
    Nephron Clin Pract; 2006; 103(3):c89-93. PubMed ID: 16534237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis B vaccine in the Gambian Expanded Programme on Immunization: factors influencing antibody response.
    Inskip HM; Hall AJ; Chotard J; Loik F; Whittle H
    Int J Epidemiol; 1991 Sep; 20(3):764-9. PubMed ID: 1835452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B vaccination in predialysis chronic renal failure patients a comparison of two vaccination schedules.
    McNulty CA; Bowen JK; Williams AJ
    Vaccine; 2005 Jul; 23(32):4142-7. PubMed ID: 15913854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of oral levamisole as an adjuvant to hepatitis B vaccine in adults with end-stage renal disease: a meta-analysis of controlled clinical trials.
    Alavian SM; Tabatabaei SV
    Clin Ther; 2010 Jan; 32(1):1-10. PubMed ID: 20171406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.